> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Court OKs $25 Million Remicade Settlement
- URL: https://www.fdaweb.com/court-oks-25-million-remicade-settlement/
- Published: 2023-03-17T12:00:00.000Z
- Updated: 2026-09-14T18:20:32.000Z
- Author: David McFarland
- Tags: Biologics, #legacy-id-D5154009

An Eastern PA federal judge has [approved](https://remicadesettlement.com/?ref=fdaweb.com) a $25 million class action settlement involving Johnson & Johnson’s Remicade (infliximab). The lawsuit (*In re Remicade Antitrust Litigation*, No. 2:17-cv-04326-KSM) claimed that defendants Johnson & Johnson and Janssen Biotech violated federal and state antitrust and consumer-protection laws by taking action to block biosimilar entrants in the marketplace. Remicade is approved for treating Crohn’s disease, ulcerative colitis, and rheumatoid arthritis.